Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,734
Total Claims
$587K
Drug Cost
581
Beneficiaries
$1,011
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+11%
Opioid rate vs peers
2.9% vs 2.6% avg
-5%
Cost per patient vs peers
$1,011 vs $1,068 avg
+5%
Brand preference vs peers
9.4% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
2.9%
Opioid Rate
250
Opioid Claims
$3,553
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 813 claims · $438K
Generic: 7,832 claims · $145K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 121 | $118K |
| Semaglutide | 52 | $54K |
| Dulaglutide | 24 | $22K |
| Empagliflozin | 22 | $18K |
| Fluticasone/Umeclidin/Vilanter | 24 | $17K |
| Atorvastatin Calcium | 1,002 | $16K |
| Budesonide/Formoterol Fumarate | 29 | $15K |
| Insulin Glargine,hum.Rec.Anlog | 18 | $12K |
| Fluticasone Propion/Salmeterol | 53 | $11K |
| Insulin Glargine,hum.Rec.Anlog | 24 | $11K |
| Rsvpref3 Antigen/As01e/Pf | 32 | $9,594 |
| Fluticasone Propionate | 18 | $8,992 |
| Insulin Glargine,hum.Rec.Anlog | 16 | $8,080 |
| Umeclidinium Brm/Vilanterol Tr | 17 | $7,680 |
| Mirabegron | 15 | $7,500 |
Prescribing Profile
Patient Profile
76
Avg Age
79%
Female
1.58
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data